Uriride 0.4mg Capsule MR may cause excessive drowsiness with alcohol.
Uriride 0.4mg Capsule MR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Uriride 0.4mg Capsule MR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Uriride 0.4mg Capsule MR is not indicated for use in women.
Uriride 0.4mg Capsule MR does not usually affect your ability to drive.
Uriride 0.4mg Capsule MR is safe to use in patients with kidney disease. No dose adjustment of Uriride 0.4mg Capsule MR is recommended. However, limited information is available on the use of Uriride 0.4mg Capsule MR in patients with end stage kidney disease. Please consult your doctor.
Uriride 0.4mg Capsule MR should be used with caution in patients with severe liver disease. Dose adjustment of Uriride 0.4mg Capsule MR may be needed. Please consult your doctor.
If you miss a dose of Uriride 0.4mg Capsule MR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)